We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.58%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.01B
AUM Growth
-$40.3M
Cap. Flow
-$81.7M
Cap. Flow %
-8.12%
Top 10 Hldgs %
53.94%
Holding
5,392
New
831
Increased
1,118
Reduced
1,635
Closed
1,628

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$303M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$59.2M
3
IYR icon
iShares US Real Estate ETF
IYR
+$17.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.7M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.4M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$26.8M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$24.6M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$24.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$24M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.2M

Sector Composition

Rank Sector Weight
1 Financials 3.27%
2 Industrials 2.61%
3 Consumer Discretionary 2.36%
4 Materials 2.25%
5 Technology 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBR icon
1326
Petrobras
PBR
$120B
$35K ﹤0.01%
3,712
-9,950
-73% -$87.3K
PHM icon
1327
Pultegroup
PHM
$24.6B
$35K ﹤0.01%
1,750
+841
+93% +$17.4K
R icon
1328
Ryder
R
$10.1B
$35K ﹤0.01%
532
+440
+478% +$28.8K
SLB icon
1329
SLB Ltd
SLB
$77B
$35K ﹤0.01%
441
-7,861
-95% -$624K
SOHU
1330
Sohu.com
SOHU
$366M
$35K ﹤0.01%
804
+735
+1,065% +$29.7K
SYNA icon
1331
Synaptics
SYNA
$4.01B
$35K ﹤0.01%
603
-6,622
-92% -$364K
ULBI icon
1332
Ultralife
ULBI
$90.3M
$35K ﹤0.01%
8,413
+3,934
+88% +$17.3K
VSTM icon
1333
Verastem
VSTM
$513M
$35K ﹤0.01%
2,180
+2,041
+1,468% +$32.9K
WLKP icon
1334
Westlake Chemical Partners
WLKP
$760M
$35K ﹤0.01%
+1,540
New +$35K
AXE
1335
DELISTED
Anixter International Inc
AXE
$35K ﹤0.01%
544
-3,676
-87% -$221K
AGIO icon
1336
Agios Pharmaceuticals
AGIO
$1.92B
$34K ﹤0.01%
+636
New +$27.7K
ATHM icon
1337
Autohome
ATHM
$2.62B
$34K ﹤0.01%
1,403
+203
+17% +$4.72K
CEMB icon
1338
iShares JPMorgan EM Corporate Bond ETF
CEMB
$405M
$34K ﹤0.01%
666
– –
FTI icon
1339
TechnipFMC
FTI
$27.5B
$34K ﹤0.01%
1,524
-332
-18% -$6.71K
HPQ icon
1340
HP
HPQ
$25.6B
$34K ﹤0.01%
2,199
-3,581
-62% -$51.1K
KPTI icon
1341
Karyopharm Therapeutics
KPTI
$45.1M
$34K ﹤0.01%
234
-43
-16% -$5.17K
MCRB icon
1342
Seres Therapeutics
MCRB
$47.1M
$34K ﹤0.01%
+136
New +$47.7K
QURE icon
1343
uniQure
QURE
$3.1B
$34K ﹤0.01%
4,386
+4,186
+2,093% +$33.2K
SPG icon
1344
Simon Property Group
SPG
$72.1B
$34K ﹤0.01%
165
+154
+1,400% +$33.4K
ST icon
1345
Sensata Technologies
ST
$6.85B
$34K ﹤0.01%
867
+844
+3,670% +$31.9K
TT icon
1346
Trane Technologies
TT
$106B
$34K ﹤0.01%
502
-4,547
-90% -$303K
JOYY
1347
JOYY Inc
JOYY
$3.78B
$34K ﹤0.01%
633
-561
-47% -$25.6K
SUM
1348
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$34K ﹤0.01%
+1,899
New +$36.8K
ATRS
1349
DELISTED
Antares Pharma, Inc.
ATRS
$34K ﹤0.01%
20,474
+12,147
+146% +$14.9K
GOV
1350
DELISTED
Government Properties Income Trust
GOV
$34K ﹤0.01%
1,493
-2,370
-61% -$55.5K
52 53
54
55 56

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
GAMH
Greenwoods Asset Management (HK) Hong Kong $3.88B AUM 23.82% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review

As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 3.3% of assets, down from 6.1% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.

  • Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
  • Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
  • Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.